These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 4655986)

  • 1. [New views on the pathophysiology of disseminated sclerosis].
    Cendrowski W
    Neurol Neurochir Pol; 1972; 6(5):817-21. PubMed ID: 4655986
    [No Abstract]   [Full Text] [Related]  

  • 2. Pathophysiology of multiple sclerosis and related clinical implications.
    Davis FA
    Mod Treat; 1970 Sep; 7(5):890-902. PubMed ID: 4933354
    [No Abstract]   [Full Text] [Related]  

  • 3. [Change in the acid-base equilibrium and its interrelationship to sodium-potassium metabolism in adaptation to multiple discontinuous heat effects].
    Afanas'ev BG
    Gig Sanit; 1973 Feb; 38(2):110-3. PubMed ID: 4779866
    [No Abstract]   [Full Text] [Related]  

  • 4. Basic and clinical electrophysiology of demyelinating diseases.
    Ritchie JM; Waxman SG; Waksman BH
    Neurology; 1981 Oct; 31(10):1308-10. PubMed ID: 6287348
    [No Abstract]   [Full Text] [Related]  

  • 5. Pathophysiology in multiple sclerosis.
    McDonald WI
    Brain; 1974 Mar; 97(1):179-96. PubMed ID: 4373118
    [No Abstract]   [Full Text] [Related]  

  • 6. Bibliography. Current world literature. Demyelinating diseases.
    Curr Opin Neurol; 2007 Jun; 20(3):358-67. PubMed ID: 17495633
    [No Abstract]   [Full Text] [Related]  

  • 7. [Etiopathogenesis of multiple sclerosis in the light of current studies].
    Strelau K
    Neurol Neurochir Pol; 1972; 6(1):93-8. PubMed ID: 4553032
    [No Abstract]   [Full Text] [Related]  

  • 8. Renal regulation of acid-base balance.
    Rector FC
    Aust N Z J Med; 1981; 11(Suppl 1):1-5. PubMed ID: 6789807
    [No Abstract]   [Full Text] [Related]  

  • 9. Complexity and heterogeneity in demyelinating disease.
    Compston A
    Brain; 2007 May; 130(Pt 5):1178-80. PubMed ID: 17472981
    [No Abstract]   [Full Text] [Related]  

  • 10. Approaches to the development of pharmacological interventions in multiple sclerosis.
    Davis FA; Schauf CL
    Adv Neurol; 1981; 31():505-10. PubMed ID: 6275674
    [No Abstract]   [Full Text] [Related]  

  • 11. Pathophysiology of demyelinating disease.
    Halliday AM; McDonald WI
    Br Med Bull; 1977 Jan; 33(1):21-7. PubMed ID: 318885
    [No Abstract]   [Full Text] [Related]  

  • 12. Membranes, myelin, and the pathophysiology of multiple sclerosis.
    Waxman SG
    N Engl J Med; 1982 Jun; 306(25):1529-33. PubMed ID: 7043271
    [No Abstract]   [Full Text] [Related]  

  • 13. Non-multiple sclerosis recurrent demyelinating disorders: an ongoing debate.
    Marchioni E; Tavazzi E; Bastianello S
    Brain; 2010 Aug; 133(Pt 8):e150; author reply e151. PubMed ID: 20435629
    [No Abstract]   [Full Text] [Related]  

  • 14. Renal tubular acidosis.
    Gennari FJ; Cohen JJ
    Annu Rev Med; 1978; 29():521-41. PubMed ID: 25607
    [No Abstract]   [Full Text] [Related]  

  • 15. Uhthoff's phenomenon as the first manifestation of multiple sclerosis in an adult male.
    Santos-Bueso E; Viera-Peláez D; Asorey-García A; Porta-Etessam J; Vinuesa-Silva JM; García-Sánchez J
    J Fr Ophtalmol; 2016 May; 39(5):e123-4. PubMed ID: 26949115
    [No Abstract]   [Full Text] [Related]  

  • 16. Ionic permeability changes in active axon membranes.
    Hille B
    Arch Intern Med; 1972 Feb; 129(2):293-8. PubMed ID: 5058552
    [No Abstract]   [Full Text] [Related]  

  • 17. [Mechanisms of lability of neurological symptoms in multiple sclerosis].
    Peresedova AV; Baĭdina EV; Trifonova OV; Aĭzenberg IV; Gnezditskiĭ VV; Barkhatova VP; Chernikova LA; Zavalishin IA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2002; Suppl():15-9. PubMed ID: 12418387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathophysiology of delayed evoked potentials in multiple sclerosis.
    Onofrj M; Bazzano S; Malatesta G; Gambi D
    Funct Neurol; 1990; 5(4):301-19. PubMed ID: 2093049
    [No Abstract]   [Full Text] [Related]  

  • 19. The pathophysiology of demyelination and the ionic basis of nerve conduction in multiple sclerosis: an overview.
    Boyden KM
    J Neurosci Nurs; 2000 Feb; 32(1):49-53, 60. PubMed ID: 10955274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Some spaces and barriers in postmortem multiple sclerosis.
    Tourtellotte WW; Parker JA
    Prog Brain Res; 1968; 29():493-525. PubMed ID: 5735306
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.